Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;39(4):793-809.
doi: 10.1007/s10554-022-02774-x. Epub 2022 Dec 21.

Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama

Silvia Aguiar Rosa  1   2 , Boban Thomas  3 , Maurizio Pieroni  4 , Niccolò Maurizi  5   6 , Mattia Zampieri  5 , Francesco Cappelli  7 , Alberto Marchi  5 , Silvia Pradella  8 , Nuno Cardim  9 , Jan Bogaert  10 , Iacopo Olivotto  5
Affiliations
Review

Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama

Silvia Aguiar Rosa et al. Int J Cardiovasc Imaging. 2023 Apr.

Abstract

Left ventricular hypertrophy (LVH) is a frequent imaging finding in the general population. In order to identify the precise etiology, a comprehensive diagnostic approach should be adopted, including the prevalence of each entity that may cause LVH, family history, clinical, electrocardiographic and imaging findings. By providing a detailed evaluation of the myocardium, cardiovascular magnetic resonance (CMR) has assumed a central role in the differential diagnosis of left ventricular hypertrophy, with the technique of parametric imaging allowing more refined tissue characterization. This article aims to establish a parallel between pathophysiological features and imaging findings through the broad spectrum of LVH entities, emphasizing the role of CMR in the differential diagnosis.

Keywords: Cardiovascular magnetic resonance; Differential diagnosis; Left ventricular hypertrophy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Levy D (1988) Left ventricular hypertrophy: epidemiological insights from the Framingham heart study. Drugs 35(5):1–5 - PubMed - DOI
    1. Armstrong AC, Gjesdal O, Almeida A, Nacif M, Wu C, Bluemke DA, Brumback LLJ (2014) Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis. Echocardiography 31(1):12–20 - PubMed - DOI
    1. Bluemke DA, Kronmal RA, Lima JAC, Liu K, Olson J, Burke GL et al (2008) The relationship of left ventricular mass and geometry to incident cardiovascular events. The MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 52(25):2148–2155 - PubMed - PMC - DOI
    1. Gupta S, Berry JD, Ayers CR, Peshock RM, Khera A, De Lemos JA et al (2010) Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease: the Dallas heart study. JACC Cardiovasc Imaging 3(6):605–613 - PubMed - DOI
    1. Brumback LC, Kronmal R, Heckbert SR, Ni H, Hundley WG, Lima JA et al (2010) Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging 26(4):459–468 - PubMed - PMC - DOI

LinkOut - more resources